Publications in Journals, Ernst R. Werner, Division of Biological Chemistry, Biocentre, Innsbruck Medical University
Active NF-E2-related factor (Nrf2) contributes to keep endothelial NO synthase (eNOS) in the coupled state: the role of reactive oxygen species (ROS)-, eNOS- and heme oxygenase (HO-1) levels. Heiss EH, Schachner D, Werner ER, Dirsch VM. J.Biol.Chem. (2009) 284: 31579-31586.
Monitoring of fatty aldehyde dehydrogenase by formation of pyrenedecanoic acid from pyrenedecanal. Keller MA, Watschinger K, Golderer G, Maglione M, Sarg B, Lindner H, Werner-Felmayer G, Terrinoni A, Wanders RJ, Werner ER. J.Lipid.Res. (2009) Doi:10.1194/jlr002220:
Proteomic profiling of acute cardiac allograft rejection. Kienzl K, Sarg B, Golderer G, Obrist P, Werner ER, Werner-Felmayer G, Lindner H, Maglione M, Schneeberger S, Margreiter R, Brandacher G. Transplantation (2009) 88: 553-560
Infiltrating
CD11b+CD11c+ cells have the potential to mediate inducible nitric
oxide synthase dependent cell death in mammary carcinomas of
HER-2/neu transgenic mice. Parajuli N,
Mülller-Holzner E, Böck G, Werner ER, Doppler W. Int.J.Cancer (2009) in press DOI 10.1002/ijc.24805 :
The amounts of alpha 1 antitrypsin protein are reduced in the vascular wall of acutely dissected human ascending aorta. Schachner T, Golderer G, Sarg B, Lindner HH, Bonaros N, Mikuz G, Laufer G, Werner ER. Eur.J.Cardiothorac.Surg. (2009) in press:doi:10.1016/j.ejcts.2009.07.025
The interplay between iron and zinc metabolism in Aspergillus fumigatus. Yasmin S, Abt B, Schrettl M, Moussa TA, Werner ER, Haas H. Fungal.Genet.Biol. (2009) 46: 707-713
Physarum nitric oxide synthases: Genomic structures and enzymology of recombinant proteins. Messner S, Leitner S, Bommassar C, Golderer G, Grobner P, Werner ER, Werner-Felmayer G. Biochem.J. (2009), 418: 691-700![]()
Interferon-gamma-mediated pathways and in vitro PBMC proliferation in HIV-infected patients. Schroecksnadel K, Winkler C, Werner ER, Sarcletti M, Romani N, Ebner S, Schennach H, Fuchs D, Zangerle R. Biol.Chem. (2009), 290: 115-123 ![]()
















Arginine vasopressin and serum nitrite/nitrate concentrations in advanced vasodilatory shock. Dunser MW, Werner ER, Wenzel V, Ulmer H, Friesenecker BE, Hasibeder WR, Mayr AJ. Acta Anaesthesiol.Scand. (2004) 48: 814-819.










Prolongued survival of murine cardiac allografts by treatment with the 4-amino analogue of tetrahydrobiopterin. Brandacher G, Zou Y, Obrist P, Steurer W, Werner-Felmayer G, Margreiter R, Werner ER. Transplant Proc. (2001) 33: 516-517.
The 4-amino analogue of tetrahydrobiopterin efficiently prolongs murine cardiac allograft survival. Brandacher G, Zou Y, Obrist P, Steurer W, Werner-Felmayer G, Margreiter R, Werner ER. J.Heart Lung Transpl. (2001) 20: 747-749.








Interaction of endothelial and neuronal nitric-oxide synthases with the bradykinin B2 receptor. Binding of an inhibitory peptide to the oxygenase domain blocks uncoupled NADPH oxidation. Golser R, Gorren ACF, Leber A, Andrew P, Habisch HJ, Werner ER, Schmidt K, Venema RC, Mayer B. J.Biol.Chem. (2000) 275: 5291-5296.

Low-temperature optical absorption spectra suggest a role for tetrahydrobiopterin in both steps of nitric oxide synthase catalysis. Gorren ACF, Bec N, Schrammel A, Werner ER, Lange R, Mayer B. Biochemistry (2000) 39: 11763-11770.
Central nervous system activation of indoleamine 2,3-dioxygenase pathway in human T-cell lymphotropic virus type I associated myelopathy/tropical spastic paraparesis. Maloney EM, Morgan OC, Widner B, Werner ER, Fuchs D. J.Inf.Dis. (2000) 181: 2037-2040.
Cloning, genomic sequence, and chromosome mapping of Scyb11, the murine homologue of SCYB11 (alias betaR1/H174/SCYB9B/I-TAC/IP- 9/CXCL11). Meyer M, Erdel M, Duba HC, Werner ER, Werner-Felmayer G. Cytogenet.Cell.Genet. (2000) 88: 278-282.
Interferon-gamma-primed monocytoid cell lines: Optimizing their use for in-vitro detection of bacterial pyrogens. Peterbauer A, Eperon S, Jungi TW, Werner ER, Werner-Felmayer G. J.Immunol.Meth. (2000) 233: 67-76.
Contrasting effects of N5-substituted tetrahydrobiopterin derivatives on phenlyalanine hydroxylase, dihydropteridine reductase and nitric oxide synthase. Werner ER, Habisch HJ, Gorren ACF, Schmidt K, Canevari L, Werner-Felmayer G, Mayer B. Biochem.J. (2000) 348: 579-583.
Structure and expression of the human small cytokine B subfamily member 11 (SCYB11, formerly SCYB9B, alias I-TAC) gene cloned from interferon-gamma treated human monocytes (THP-1). Laich A, Meyer M, Werner ER, Werner-Felmayer G. J.Interferon and Cytokine Res. (1999) 19: 505-513.
Weiterentwicklung eines Zellkulturmodells zum Nachweis bakterieller Pyrogene. Peterbauer A, Werner ER, Werner-Felmayer G. Altex (1999) 16: 3-8.
Neopterin and nitrite in supernatants from interferon-gamma treated monocytoid cell lines: A tool to identify bacterial pyrogens. Peterbauer A, Werner ER, Werner-Felmayer G. Pteridines (1999) 10: 112-118.
Electronic structure of tetrahydropteridine derivatives. Reibnegger G, Pauschenwein J, Werner ER. Pteridines (1999) 10: 91-94.
Activation of neuronal nitric oxide synthase by the 5-methyl analog of tetrahydrobiopterin. Functional evidence against reductive oxygen activation by the pterin cofactor. Riethmüller C, Gorren ACF, Pitters E, Hemmens B, Habisch HJ, Heales SJR, Schmidt K, Werner ER, Mayer B. J.Biol.Chem. (1999) 274: 16047-16051.
Preferential inhibition of inducible nitric oxide synthase by the 4-amino analogue of tetrahydrobiopterin in cultured cells. Schmidt K, Werner-Felmayer G, Mayer B, Werner ER. Eur.J.Biochem. (1999) 259: 25-31.
Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. Cosentino F, Patton S, d’Uscio LV, Werner ER, Werner-Felmayer G, Moreau P, Malinski T, Luscher TF. J.Clin.Invest. (1998) 101: 1530-1537.
The human gene encoding SCYB9B, a putative novel CXC chemokine, maps to human chromosome 4q21 like the closely related genes for MIG (SCYB9) and INP10 (SCYB10). Erdel M, Laich A, Utermann G, Werner ER, Werner-Felmayer G. Cytogenet.Cell.Genet. (1998) 81: 271-272.
Coordinated induction of inducible nitric oxide synthase and GTP- cyclohydrolase I is dependent on inflammatory cytokines and interferon- gamma in HaCaT keratinocytes: implications for the model of cutaneous wound repair. Frank S, Kolb N, Werner ER, Pfeilschifter J. J.Invest.Dermatol. (1998) 111: 1065-1071.
Haem insertion, dimerization and reactivation of haem-free rat neuronal nitric oxide synthase. Hemmens B, Gorren ACF, Schmidt K, Werner ER, Mayer B. Biochem.J. (1998) 332: 337-342.
Protein kinase C phosphorylates and activates GTP cyclohydrolase I in rat renal mesangial cells. Lapize C, Pluss C, Werner ER, Huwiler A, Pfeilschifter J. Biochem.Biophys.Res.Commun. (1998) 251: 802-805.
6-Tetrahydrobiopterin functions as a UVB-light switch for de novo melanogenesis. Schallreuter KU, Wood JM, Korner C, Harle KM, Schulz-Douglas V, Werner ER. Biochim.Biophys.Acta. (1998) 1382: 339-344.
Rat GTP cyclohydrolase I is a homodecameric protein complex containing high-affinity calcium-binding sites. Steinmetz MO, Pluss C, Christen U, Wolpensinger B, Lustig A, Werner ER, Wachter H, Engel A, Aebi U, Pfeilschifter J, Kammerer RA. J.Mol.Biol. (1998) 279: 189-199.
Cerebrospinal fluid levels of biopterin, nitric oxide metabolites, and immune activation markers and the clinical course of human cerebral malaria. Weiss G, Thuma PE, Biemba G, Mabeza G, Werner ER, Gordeuk VR. J.Infect.Dis. (1998) 177: 1064-1068.
Minireview: Tetrahydrobiopterin, cytokines and nitric oxide synthesis. Werner ER, Werner-Felmayer G, Mayer B. Proc.Soc.Exp.Biol.Med. (1998) 219: 171-182.
trans-Activation of the HIV type 1 promoter by 7,8- dihydroneopterin in vitro. Baier Bitterlich G, Fuchs D, Zangerle R, Baeuerle PA, Werner ER, Fresser F, Uberall F, Baier G, Wachter H. AIDS.Res.Hum.Retroviruses. (1997) 13: 173-178.
Tetrahydrobiopterin in the treatment of infantile hypertrophic pyloric stenosis. Braegger CP, Schwobel M, Kanel J, Werner ER, Thony B, Blau N. Biochem.Mol.Med. (1997) 62: 101-105.
Characterization of the inducible nitric oxide synthase oxygenase domain identifies a 49 amino acid segment required for subunit dimerization and tetrahydrobiopterin interaction. Ghosh DK, Wu C, Pitters E, Moloney M, Werner ER, Mayer B, Stuehr DJ. Biochemistry. (1997) 36: 10609-10619.

Tetrahydrobiopterin binding to macrophage inducible nitric oxide synthase expressed in Escherichia coli. Heme spin shift and dimer stabilization by the potent pterin antagonist 4-amino tetrahydrobiopterin. Mayer B, Wu C, Gorren ACF, Pfeiffer S, Schmidt K, Clark P, Stuehr DJ, Werner ER. Biochemistry (1997) 36: 8422-8427.
Metabolic fate of peroxynitrite in aqueous solution. Reaction with nitric oxide and pH-dependent decomposition to nitrite and oxygen in a 2:1 stoichiometry. Pfeiffer S, Gorren ACF, Schmidt K, Werner ER, Hansert B, Bohle DS, Mayer B. J.Biol.Chem. (1997) 272: 3465-3470.
Allosteric modulation of rat brain nitric oxide synthase by the pterin-site enzyme inhibitor 4-amino tetrahydrobiopterin. Pfeiffer S, Gorren ACF, Pitters E, Schmidt K, Werner ER, Mayer B. Biochem.J. (1997) 328: 349-352.
Interference of Carboxy-PTIO with nitric oxide- and peroxynitrite-mediated reactions. Pfeiffer S, Leopold E, Hemmens B, Schmidt K, Werner ER, Mayer B. Free Rad.Biol.Med. (1997) 22: 787-794.
Differential effect of dexamethasone on interleukin 1beta- and cyclic AMP-triggered expression of GTP cyclohydrolase I in rat renal mesangial cells. Plüss C, Werner ER, Wachter H, Pfeilschifter J. Br.J.Pharmacol. (1997) 122: 534-538.
Modulary potential of iron chelation therapy on nitric oxide formation in cerebral malaria. Weiss G, Thuma PE, Mabeza G, Werner ER, Herold M, Gordeuk VR. J.Infect.Dis. (1997) 175: 226-230.
Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Widner B, Werner ER, Schennach H, Wachter H, Fuchs D. Clin.Chem. (1997) 43: 2424-2426.
Differential regulation of inducible nitric oxide synthase production in bovine and caprine macrophages. Adler H, Adler B, Peveri P, Werner ER, Wachter H, Peterhans E, Jungi TW. J.Inf.Dis. (1996) 173: 971-978.
Tetrahydrobiopterin-free neuronal nitric oxide synthase: Evidence for two identical highly anticooperative pteridine binding sites. Gorren ACF, List BM, Schrammel A, Pitters E, Hemmens B, Werner ER, Schmidt K, Mayer B. Biochemistry (1996) 35: 16735-16745.
Characterization of heme-deficient neuronal NO synthase reveals a role for heme in subunit dimerization and binding of the amino acid substrate and tetrahydrobiopterin. Klatt P, Pfeiffer S, List BM, Lehner D, Glatter O, Bächinger HP, Werner ER, Schmidt K, Mayer B. J.Biol.Chem. (1996) 271: 7336-7342.
Overexpression of neuronal nitric oxide synthase in insect cells reveals requirement of heme for tetrahydrobiopterin binding. List BM, Klatt P, Werner ER, Schmidt K, Mayer B. Biochem.J. (1996) 315: 57-63.
Effects of neopterin derivatives on H2O2-induced luminol chemiluminescence: mechanistic aspects. Murr C, Baier-Bitterlich G, Fuchs D, Werner ER, Esterbauer H, Pfleiderer W, Wachter H. Free Rad.Biol.Med. (1996) 21: 449-456.
Interleukin-1 beta and cAMP trigger the expression of GTP cyclohydrolase I in rat renal mesangial cells. Plüss C, Werner ER, Blau N, Wachter H, Pfeilschifter J. Biochem.J. (1996) 318: 665-671.
Pteridine and nitrite/nitrate formation in experimental spetic and traumatic shock. Strohmaier W, Werner ER, Wachter H, Redl H, Schlag G. Shock (1996) 6: 254-258.

High performance liquid chromatographic methods for the quantification of tetrahydrobiopterin biosynthetic enzymes. Werner ER, Werner-Felmayer G, Wachter H. J.Chromatogr. (1996) 684B: 51-58.
Biosynthesis of nitric oxide: Dependence on pteridine metabolism. Werner ER, Werner-Felmayer G, Wachter H, Mayer B. Rev.Physiol.Biochem.Pharmacol. (1996) 127: 97-135.
Brain biopterin metabolism in chrinic experimental hepatic encephalopathy. Bergvist PBF, Werner ER, Apelqvist G, Bugge M, Wachter H, Bengtson F. Metabol.Brain Dis. (1995) 10: 143-157.
2,4-Diamino-6-hydroxypyrimidine, an inhibitor of tetrahydrobiopterin synthesis, downregulates the expression of iNOS protein and mRNA in primary murine macrophages. Bogdan C, Werner ER, Stenger S, Wachter H, Röllinghoff M, Werner-Felmayer G. FEBS Lett. (1995) 363: 69-74.
Neopterin als immundiagnostische Mebgröbe. Fuchs D, Baier-Bitterlich G, Hausen A, Murr C, Weiss G, Werner ER, Werner-Felmayer G, Reibnegger G. Deutsch.Med.Wochenschr. (1995) 120: 567-570.
In search of a function for tetrahydrobiopterin in the biosynthesis of nitric oxide. Mayer B, Werner ER. Naunyn – Schmiedebergs Arch.Pharmacol. (1995) 351: 453-463.
Kinetics and mechanism of tetrahydrobiopterin-induced oxidation of nitric oxide. Mayer B, Klatt P, Werner ER, Schmidt K. J.Biol.Chem. (1995) 270: 655-659.
Nitric-oxide modulates the release of acetylcholine in the vental striatum of the freely moving rat. Prast H, Fischer H, Werner ER, Werner-Felmayer G, Phillipu
A. Naunyn – Schmiedebergs Arch.Pharmacol. (1995) 352: 67-73.
Plasma nitrate and pteridine levels in experimental bacteremia in baboons. Strohmaier W, Werner ER, Redl H, Wachter H, Schlag G. Pteridines (1995) 6: 8-11.
Nitric oxide formation as predictive parameter for acute graft- versus-host disease after human allogeneic bone marrow transplantation. Weiss G, Schwaighofer H, Herold M, Nachbaur D, Wachter H, Niederwieser D, Werner ER. Transplantation (1995) 60: 1239-1244.
Detection of bacterial pyrogens on the basis of their effects on gamma interferon-mediated formation of neopterin or nitrite in cultured monocyte cell lines. Werner-Felmayer G, Baier-Bitterlich G, Fuchs D, Hausen A, Murr C, Reibnegger G, Werner ER, Wachter H. Clin.Diagn.Lab.Immunol. (1995) 2: 307-313.
Serum nitrite plus nitrate in infection with human immunodeficiency virus type-1. Zangerle R, Fuchs D, Reibnegger G, Werner-Felmayer G, Gallatti H, Wachter H, Werner ER. Immunobiol. (1995) 193: 59-70.
Nitric oxide synthase and antimicrobial armature of human macrophages. Fuchs D, Murr C, Reibnegger G, Weiss G, Werner ER, Werner-Felmayer G, Wachter H. J.Infect.Dis. (1994) 169: 224.

Identification of imidazole as L-arginine-competitive inhibitor of porcine brain nitric oxide synthase. Mayer B, Klatt P, Werner ER, Schmidt K. FEBS Lett. (1994) 350: 199-202.
Molecular mechanisms of inhibition of brain nitric oxide synthase by the antinociceptive drug 7-nitro-indazole. Mayer B, Klatt P, Werner ER, Schmidt K. Neuropharmacology (1994) 33: 1253-1259.
Applicability of an enzyme-linked immunosorbant assay for neopterin detection for screening of blood donations. Mayersbach P, Augustin R, Schennach H, Fuchs D, Werner ER, Schönitzer D, Wachter H, Reibnegger G. Pteridines (1994) 5: 49-54.
Commercial enzyme-linked immunosorbent assay for neopterin detection in blood donations compared with RIA and HPLC. Mayersbach P, Augustin R, Schennach H, Schönitzer D, Werner ER, Wachter H, Reibnegger G. Clin.Chem. (1994) 40: 265-266.
Enhancement of hydrogen peroxide-induced luminol-dependent chemiluminescence by neopterin depends on the presence of iron chelator complexes. Murr C, Fuchs D, Gössler W, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Esterbauer H, Wachter H. FEBS Lett. (1994) 338: 223-226.
Iron regulates nitric oxide synthase activity by controlling nuclear transcription. Weiss G, Werner-Felmayer G, Werner ER, Grünewald K, Wachter H, Hentze MW. J.Exp.Med. (1994) 180: 969-976.

Synthesis and characterization of 3H-labelled tetrahydrobiopterin. Werner ER, Schmid M, Werner-Felmayer G, Mayer B, Wachter H. Biochem.J. (1994) 304: 189-193.
Determination of neopterin, a marker of cell-mediated immunity, in gynecologic oncology. Fuith LC, Czarnecki M, Fuchs D, Hausen A, Reibnegger G, Weiss G, Werner ER, Werner-Felmayer G, Wachter H. Int.J.Feto-Maternal Med. (1993) 6: 235-238.
Particulate endothelial nitric oxide synthase: Requirement and content of tetrahydrobiopterin, FAD, and FMN. Pollock JS, Werner ER, Mitchell JA, Förstermann U. Endothelium (1993) 1: 147-152.
Neopterin modulates toxicity mediated by reactive oxygen and chloride species. Weiss G, Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Semenitz E, Dierich MP, Wachter H. FEBS Lett. (1993) 321: 89-92.
Ca(2+)/calmodulin-dependent nitric oxide synthase activity in the human cervix carcinoma cell line ME-180. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Mayer B, Reibnegger G, Weiss G, Wachter H. Biochem.J. (1993) 289: 357-361.
Induction of GTP cyclohydrolase I by bacterial lipopolysaccharide in the rat. Werner-Felmayer G, Prast H, Werner ER, Philippu A, Wachter H. FEBS Lett. (1993) 322: 223-226.
Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Schmidt K, Weiss G, Wachter H. J.Biol.Chem. (1993) 268: 1842-1846.
Tetrahydrobiopterin and cytokines. Werner ER, Werner-Felmayer G, Wachter H. Proc.Soc.Exp.Biol.Med. (1993) 203: 1-12.
Stimulation of human nitric oxide synthase by tetrahydrobiopterin and selective binding of the cofactor. Klatt P, Heinzel B, Mayer B, Ambach E, Werner-Felmayer G, Wachter H, Werner ER. FEBS Lett. (1992) 305: 160-162.
Tetrahydrobiopterin-dependent formation of endothelium-derived relaxing factor (nitric oxide) in aortic endothelial cells. Schmidt K, Werner ER, Mayer B, Wachter H, Kukovetz R. Biochem.J. (1992) 281: 297-300.
Iron modulates interferon-gamma effects in the human myelomonocytic cell line THP-1. Weiss G, Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Wachter H. Exp.Hematol. (1992) 20: 605-610.
Neopterin does not induce release from peripheral blood mononuclear cells. Werner-Felmayer G, Werner ER, Reibnegger G, Wachter H. Scand.J.Clin.Lab.Invest. (1992) 52: 65-66.
Tetrahydrobiopterin biosynthesis inhibition for diminishing nitric oxide production in cytokine-mediated septic shock. Werner-Felmayer G, Werner ER, Weiss G, Wachter H. J.Nat.Cancer Inst. (1992) 84: 1671-1672.
Tetrahydrobiopterin-dependent conversion of L-arginine to L- citrulline and nitric oxide in murine and human cells. Werner-Felmayer G, Werner ER, Weiss G, Wachter H. Pteridines (1992) 3: 53-54.
Current knowledge on pteridine dependence of nitric oxide synthase. Werner ER, Mayer B, Prast H, Schmidt K, Werner-Felmayer G, Weiss G, Wachter H. Pteridines (1992) 3: 49-50.
Kynurenine in cerebrospinal fluid of patients with lyme neuroborreliosis. Fuchs D, Dotevall L, Hagberg L, Werner ER, Wachter H. Immunol.Infect.Dis. (1991) 1: 271-274.
Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection. Fuchs D, Möller AA, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H. Immunol.Lett. (1991) 28: 207-212.
Neopterin – ein biochemischer Marker für Immunaktivierung bei Transplantatabstobung, Infektionen, Autoimmunerkrankungen und Tumoren. Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Tilz GP, Wachter H. Mitt.Oesterr.Ges.Haematol.Onkol. (1991) 1.
Neopterin and b2-microglobulin as prognostic indices in human immunodeficiency virus type 1 infection. Fuchs D, Krämer A, Reibnegger G, Werner ER, Dierich MP, Goedert JJ, Wachter H. Infection (1991) 19: 98-102.
Negative correlation between blood cell counts and serum neopterin concentrations in patients with HIV-1 infection. Fuchs D, Shearer GM, Boswell RN, Lucey DR, Clerici M, Reibnegger G, Werner ER, Zajac RA, Wachter H. AIDS (1991) 5: 209-212.
Low haemoglobin in haemophilia children is associated with chronic immune activation. Fuchs D, Reibnegger G, Werner ER, Vinazzer H, Wachter H. Acta Haematol. (1991) 85: 62-65.
Immune activation and the anaemia associated with chronic inflammatory disorders. Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H. Eur.J.Haematol. (1991) 46: 65-70.
Neopterin, a marker of cell-mediated immune activation in human pregnancy. Fuith LC, Fuchs D, Hausen A, Hetzel H, Reibnegger G, Werner ER, Wachter H. Int.J.Fertil. (1991) 36: 372-375.
Brain nitric oxide synthase is a biopterin- and flavin- containing multi-functional oxido-reductase. Mayer B, John M, Heinzel B, Werner ER, Wachter H, Schultz G, Böhme E. FEBS Lett. (1991) 288: 187-191.
Neopterin as a marker for activated cell-mediated immunity: Application in malignant disease. Reibnegger G, Fuchs D, Fuith LC, Hausen A, Werner ER, Werner-Felmayer G, Wachter H. Cancer Detect.Prevent. (1991) 15: 483-490.
Posttransplant neopterin excretion in renal allograft recipients – A reliable diagnostic aid for acute rejection and a predictive marker of long-term graft survival. Reibnegger G, Aichberger C, Fuchs D, Hausen A, Spielberger M, Werner ER, Margreiter R, Wachter H. Transplantation (1991) 52: 58-63.
Change in HIV-antibody seroprevalence rates in i.v. drug dependent prisoners. Sperner-Unterweger B, Fuchs D, Fleischhacker WW, Hausen A, Miller C, Möst J, Reibnegger G, Werner ER, Dierich MP, Wachter H, Hinterhuber H. Brit.J.Addict. (1991) 86: 225-232.
Association between neopterin and iron metabolism in cancer patients. Wachter H, Artner-Dworzak E, Fuchs D, Fuith LC, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP. Tumor Diagnostik & Therapie (1991) 11: 229-232.
Postoperative delirium and plasma tryptophan. Weiss G, Werner ER, Werner-Felmayer G, Wachter H. Lancet (1991) 338: 1078.
On multiple forms of NO synthase and their occurrence in human cells. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. Res.Immunol. (1991) 142: 555-561.
Peak E contaminated L-tryptophan and immune activation. Werner-Felmayer G, Werner ER, Weiss G, Wachter H. Lancet (1991) 338: 511.
Impact of tumour necrosis factor-alpha and interferon-gamma on tetrahydrobiopterin synthesis in murine fibroblasts and macrophages. Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G, Yim JJ, Wachter H. Biochem.J. (1991) 280: 709-714.
Biochemistry and function of pteridine synthesis in human and murine macrophages. Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G, Yim JJ, Wachter H. Pathobiol. (1991) 59: 276-279.
6-Pyruvoyl tetrahydropterin synthase assay in extracts of cultured human cells using high-performance liquid chromatography with fluorescence detection of biopterin. Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G, Wels G, Yim JJ, Pfleiderer W, Wachter H. J.Chromatogr. (1991) 570: 43-50.
Correlation between neopterin, interferon-gamma and haemoglobin in patients with haematological disorders. Denz H, Fuchs D, Huber H, Nachbaur D, Reibnegger G, Thaler J, Werner ER, Wachter H. Eur.J.Haematol. (1990) 44: 186-189.
Urinary neopterin in monoclonal gammopathies. Denz H, Fuchs D, Hausen A, Huber H, Nachbaur D, Reibnegger G, Thaler J, Werner ER, Wachter H. Pteridines (1990) 2: 107-109.
Value of urinary neopterin in the differential diagnosis of bacterial and viral infections. Denz H, Fuchs D, Hausen A, Huber H, Nachbaur D, Reibnegger G, Thaler J, Werner ER, Wachter H. Klin.Wochenschr. (1990) 68: 218-222.
Urinary excretion of porphyrins is increased in patients with HIV-1 infection. Fuchs D, Artner-Dworzak E, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H. AIDS (1990) 4: 341-344.
Immune-mediated mechanisms in multiple sclerosis. Fuchs D, Reibnegger G, Werner ER, Wachter H. J.Neurol. (1990) 237: 125.
Furunculosis and hypoferraemia. Fuchs D, Hausen A, Reibnegger G, Werner ER, Wachter H. Lancet (1990) ii: 1326.
Immune activation markers to predict AIDS and survival in HIV-1 seropositives. Fuchs D, Jäger H, Popescu M, Reibnegger G, Werner ER, Dierich MP, Kaboth W, Tilz GP, Wachter H. Immunol.Lett. (1990) 26: 75-80.
Comparison of serum and urine neopterin concentrations in patients with HIV-1 infection. Fuchs D, Jäger H, Popescu M, Reibnegger G, Werner ER, Kaboth W, Wachter H. Clin.Chim.Acta (1990) 187: 125-130.
Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. Fuchs D, Möller AA, Reibnegger G, Stöckle E, Werner ER, Wachter H. J.Acq.Immune Def.Synd. (1990) 3: 873-876.
Immune activation and decreased tryptophan in patients with HIV- 1 infection. Fuchs D, Forsman A, Hagberg L, Larsson M, Norkrans G, Reibnegger G, Werner ER, Wachter H. J.Interferon Res. (1990) 10: 599-603.
Distinct neopterin excretion patterns after vaccination. Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Wachter H. Pteridines (1990) 2: 147-149.
Increased 7,8-dihydroneopterin and reduced methyl-group metabolism in HIV-1 infection. Fuchs D, Reibnegger G, Werner ER, Wachter H. Lancet (1990) i: 1167.
Increased serum neopterin in patients with HIV-1 infection is correlated with reduced in vitro interleukin-2 production. Fuchs D, Shearer GM, Boswell RN, Clerici M, Reibnegger G, Werner ER, Zajac RA, Wachter H. Clin.Exp.Immunol. (1990) 80: 44-48.
Decreased haemoglobin and chronic immune activation in patients with gynaecological malignancies. Fuith LC, Fuchs D, Hausen A, Heim K, Schröcksnadel H, Reibnegger G, Werner ER, Wachter H. Eur.J.Haematol. (1990) 45: 280-282.
Urinary neopterin excretion in patients with uterine sarcomas. Fuith LC, Fuchs D, Hausen A, Hetzel H, Reibnegger G, Werner ER, Wachter H. Cancer (1990) 65: 1228-1231.
Urinary neopterin as marker for disease activity in children and adolescents with Crohn`s disease. Granditsch G, Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Wachter H. Pteridines (1990) 2: 23-27.
Reduction of ferric iron by 7,8-dihydroneopterin. Hausen A, Fuchs D, Reibnegger G, Werner ER, Werner-Felmayer G, Wachter H. Pteridines (1990) 2: 83-85.
Pregnancy increases urinary neopterin levels in human immunodeficiency virus type 1 infection. Mayr P, Fuchs D, Fuith LC, Reibnegger G, Werner ER, Dapunt O, Wachter H. Pteridines (1990) 2: 161-164.
Changes of neopterin and tryptophan in serum and cerebrospinal fluid of patients in different stages of HIV-1 infection. Möller AA, Fuchs D, Reibnegger G, Zaudig M, Werner ER, Wachter H. Pteridines (1990) 2: 91-93.
Neopterin and cellular immune activation in active gynaecological cancer: Significant correlation between neopterin and circulating number of HLA-DR expressing lymphocytes. Reibnegger G, Denz HA, Fuchs D, Fuith LC, Gattringer C, Hausen A, Huber H, Werner ER, Werner-Felmayer G, Wachter H. Pteridines (1990) 2: 17-21.
Urinary neopterin concentrations and T-cell subset data in HIV-1 infection. Reibnegger G, Fuchs D, Goedert JJ, Hausen A, Krämer A, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H. Klin.Wochenschr. (1990) 68: 43-48.
Unconjugated pteridines and the activation of macrophages by interferon-gamma. Reibnegger G, Fuchs D, Hausen A, Werner ER, Werner-Felmayer G, Wachter H. Cancer Chemother.Pharmacol. (1990) 25: 308-309.
Verallgemeinertes Likelihood-Ratio-Konzept und logistische Regressionsanalyse zur Schätzung von Post-Test Wahrscheinlichkeiten bei Vorliegen von mehr als zwei diagnostischen Kategorien. Reibnegger G, Fuchs D, Hausen A, Werner ER, Werner-Felmayer G, Wachter H. Ber.Oesterr.Ges.Klin.Chem. (1990) 2: 45-49.
Tetrahydrobiopterin-dependent formation of nitrite and nitrate in murine fibroblasts. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. J.Exp.Med. (1990) 172: 1599-1607.
Neopterin formation and tryptophan degradation by a human myelomonocytic cell line (THP-1). Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. Cancer Res. (1990) 50: 2863-2867.
Tetrahydrobiopterin biosynthetic activities in human macrophages, fibroblasts, THP-1 and T 24 cells. GTP-cyclohydrolase I is stimulated by interferon-gamma, 6-pyruvoyl tetrahydropterin synthase and sepiapterin reductase are constitutively present. Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G, Yim JJ, Pfleiderer W, Wachter H. J.Biol.Chem. (1990) 265: 3189-3192.
Urinary neopterin as a prognostic factor in haematological neoplasias. Denz H, Grünewald K, Thaler J, Huber H, Fuchs D, Hausen A, Reibnegger G, Werner ER, Wachter H. Pteridines (1989) 1: 167-170.
b2-Microglobulin and immune activation. Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Wachter H. Clin.Chem. (1989) 35: 2158-2159.
Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1. Fuchs D, Chiodi F, Albert J, Asjö B, Hagberg L, Hausen A, Norkrans G, Reibnegger G, Werner ER, Wachter H. AIDS (1989) 3: 285-288.
AIDS incidence rates in Austria. Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H. Wien.Klin.Wochenschr. (1989) 101: 388-390.
Urinary neopterin concentrations vs total neopterins for clinical utility. Fuchs D, Milstien S, Krämer A, Reibnegger G, Werner ER, Goedert JJ, Kaufman S, Wachter H. Clin.Chem. (1989) 35: 2305-2307.
Cell-mediated immunoreactivity in AIDS. Fuchs D, Werner ER, Dierich MP, Wachter H. Immunol.Today (1989) 10: 150.
Endogenous release of interferon-gamma and diminished response of peripheral blood mononuclear cells to antigenic stimulation. Fuchs D, Malkovsky M, Reibnegger G, Werner ER, Forni G, Wachter H. Immunol.Lett. (1989) 23: 103-108.
Neopterin as a predictive marker for disease progression in human immunodeficiency virus type 1 infection. Fuchs D, Spira TJ, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Wachter H. Clin.Chem. (1989) 35: 1746-1749.
Interferon-gamma concentrations are increased in sera from individuals infected with human immunodeficiency virus type 1. Fuchs D, Hausen A,
Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H. J.Acq.Immune Def.Synd. (1989) 2: 158-162.
Effects of interferon-alpha on macrophage activation in patients with ovarian carcinoma and cervical dysplasia. Fuith LC, Fuchs D, Hausen A, Hetzel H, Reibnegger G, Werner ER, Wachter H. J.Clin.Lab.Immunol. (1989) 29: 65-69.
Neopterin in clinical use. Hausen A, Fuchs D, Reibnegger G, Werner ER, Wachter H. Pteridines (1989) 1: 3-10.
Application of neopterin – a marker for activation of cellular immunity – in clinical chemistry. Hausen A, Fuchs D, Reibnegger G, Werner ER, Werner-Felmayer G, Wachter H. Sci.Pharm. (1989) 57: 249-264.
Serum-Neopterinbestimmung zur zusätzlichen Sicherung der Bluttransfusion. Hönlinger M, Fuchs D, Hausen A, Reibnegger G, Schönitzer D, Werner ER, Reissigl H, Dierich MP, Wachter H. Deutsch.Med.Wochenschr. (1989) 114: 172-176.
Monitoring of serum neopterin levels for diagnosis of acute rejection of renal allografts. Reibnegger G, Fuchs D, Hausen A, Werner ER, Werner-Felmayer G, Wachter H. Nephron (1989) 52: 100.
Generalization of the likelihood ratio concept for diagnostic tests with multiple diagnostic categories. Reibnegger G, Fuchs D, Hausen A, Werner ER, Werner-
Felmayer G, Wachter H. J.Clin.Epidemiol. (1989) 42: 477-478.
Generalized likelihood ratio concept and logistic regression analysis for multiple diagnostic categories. Reibnegger G, Fuchs D, Hausen A, Werner ER, Werner-Felmayer G, Wachter H. Clin.Chem. (1989) 35: 990-994.
Neopterin and viral infections: diagnostic potential in virally induced liver disease. Reibnegger G, Fuchs D, Hausen A, Werner ER, Wachter H. Biomed.Pharmacother. (1989) 43: 287-293.
Concentrations of neopterin in serum of recipients of renal allografts. Reibnegger G, Fuchs D, Hausen A, Werner ER, Werner-Felmayer G, Wachter H. Clin.Chem. (1989) 35: 2157.
Correlation of serum interferon-gamma and neopterin concentrations in Africans with various diseases. Reibnegger G, Fuchs D, Hausen A, Schmutzhard E, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H. Pteridines (1989) 1: 119-124.
Outcome prediction in intensive care. Reibnegger G, Werner ER, Wachter H. Lancet (1989) ii: 330.
Stability analysis of simple models for immune cells interacting with normal pathogens and immune system retroviruses. Reibnegger G, Fuchs D, Hausen A, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H. Proc.Natl.Acad.Sci.(USA) (1989) 86: 2026-2030.
Retroviral infections (HIV-1, HIV-2, and HTLV-I) in rural northwestern Tanzania. Schmutzhard E, Fuchs D, Hengster P, Hausen A, Hofbauer J, Pohl P, Rainer J, Reibnegger G, Tibyampansha D, Werner ER, Dierich MP, Gerstenbrand F, Wachter H. Am.J.Epidemiol. (1989) 130: 309-318.
Neopterin as marker for activation of cellular immunity: Immunologic basis and clinical application. Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER. Adv.Clin.Chem. (1989) 27: 81-141.
Neopterin bei Infektionen mit dem humanen Immunmangelvirus (HIV). Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP. Extracta Dermatologica (1989) 13: 82-83.
Tumour necrosis factor-alpha and lipopolysaccharide enhance interferon-induced tryptophan degradation and pteridine synthesis in human cells. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. Biol.Chem.Hoppe Seyler (1989) 370: 1063-1069.
Characteristics of interferon induced tryptophan metabolism in human cells in vitro. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. Biochim.Biophys.Acta (1989) 1012: 140-147.
Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-gamma. Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G, Wachter H. Biochem.J. (1989) 262: 861-866.
Selective induction of mononuclear phagocytes to produce neopterin by interferons. Bitterlich G, Szabo G, Werner ER, Larcher C, Fuchs D, Hausen A, Reibnegger G, Schulz TF, Troppmair J, Wachter H, Dierich MP. Immunobiol. (1988) 176: 228-235.
Aluminium und Dihydropteridin-Reduktase beim M.Alzheimer. Fuchs D, Werner ER, Wachter H. Deutsch.Med.Wochenschr. (1988) 113: 877.
I
s T-cell activation an unfavourable sign in iv-drug addicts infected with HIV? Fuchs D, Hausen A, Hengster P, Reibnegger GJ, Unterweger B, Werner ER, Hinterhuber H, Dierich MP, Wachter H. Cancer Detect.Prevent. (1988) 12: 277-282.
Antigen detection in primary HIV infection. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. Brit.Med.J. (1988) 296: 714-715.
Cellular immune activation in the brain and human immunodeficiency virus infection. Fuchs D, Werner ER, Dierich MP, Wachter H. Ann.Neurol. (1988) 24: 289.
Immunological status and HIV antibodies in patients with haemophilia – a longitudinal study. Fuchs D, Hausen A, Reibnegger G, Werner ER, Vinazzer H, Dierich MP, Wachter H. Wien.Klin.Wochenschr. (1988) 100: 505-509.
Anti-HIV-1 antibodies, anti-HTLV-I antibodies and neopterin levels in parenteral drug addicts in the Austrian Tyrol. Fuchs D, Unterweger B, Hausen A, Reibnegger G, Werner ER, Hengster P, Hinterhuber H, Dierich MP, Wachter H, Blattner WA, Weiss SH. J.Acq.Immune Def.Synd. (1988) 1: 65-66.
Neopterin levels in long term hemodialysis. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dittrich P, Wachter H. Clin.Nephrol. (1988) 30: 220-224.
Neopterin estimation compared with the ratio of T-cell subpopulations in persons infected with human immunodeficiency virus 1. Fuchs D, Banekovich M, Hausen A, Hutterer J, Reibnegger G, Werner ER, Gschnait FD, Dierich MP, Wachter H. Clin.Chem. (1988) 34: 2415-2417.
Neopterin as a marker in HIV infection. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. Clin.Chem. (1988) 34: 466-467.
Neopterin as a marker for activated cell-mediated immunity: Application in HIV infection. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. Immunol.Today (1988) 9: 150-155.
Neopterin in clinical medicine. Fuchs D, Hausen A, Reibnegger G, Werner ER, Wachter H. Lancet (1988) i: 702.
Urinary neopterin in infants with primary immunodeficiency. Fuchs D, Ebell W, Friedrich W, Hausen A, Reibnegger G, Werner ER, Wachter H. Immunobiol. (1988) 177: 1-6.
Preactivated T-cells in cancer patients with poor prognosis. Fuchs D, Fuith LC, Hausen A, Hetzel H, Reibnegger GJ, Werner ER, Wachter H. Cancer Detect.Prevent. (1988) 12: 97-103.
Cytomegalovirus infection. Fuchs D, Hausen A, Reibnegger G, Werner ER, Wachter H. Wien.Klin.Wochenschr. (1988) 100: 303.
Toxic properties of the mushroom Cortinarius orellanus. I.Chemical characterization of the main toxin of Cortinarius orellanus (Fries) and Cortinarius speciosissimus (Kühn & Romagn) and acute toxicity in mice. Prast H, Werner ER, Pfaller W, Moser M. Arch.Toxicol. (1988) 62: 81-88.
Urinary neopterin excretion in pulmonary sarcoidosis: correlation to clinical course of the disease. Prior C, Frank A, Fuchs D, Hausen A, Judmaier G, Reibnegger G, Werner ER, Wachter H. Clin.Chim.Acta (1988) 177: 211-220.
Approach to define „normal aging“ in man. Immune function, serum lipids, lipoproteins and neopterin levels. Reibnegger G, Huber LA, Jürgens G, Schönitzer D, Werner ER, Wachter H, Wick G, Traill KN. Mech.Ageing Dev. (1988) 46: 67-82.
Urinary neopterin levels in acute viral hepatitis. Reibnegger G, Auhuber I, Fuchs D, Hausen A, Judmaier G, Prior C, Werner ER, Wachter H. Hepatology (1988) 8: 771-774.
Pterins as biochemical tests for diagnosis and management of patients with malignant lymphoma and leukemia. Reibnegger G, Fuchs D, Hausen A, Werner ER, Wachter H. Clin.Chim.Acta (1988) 173: 233-234.
Neopterin in der HIV-Infektion. Reibnegger G, Fuchs D, Hausen A, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H. Antibiot.Monitor. (1988) 81-82.
The prognostic value of neopterin as a marker for the immune status in malignancy. Reibnegger G, Fuchs D, Fuith LC, Hausen A, Hetzel H, Werner ER, Wachter H. J.Tumor Marker Oncol. (1988) 3: 121-125.
Retrovirale Infektionen in Norwest-Tanzania (HIV 1, HIV II, HTLV I). Schmutzhard E, Fuchs D, Hausen A, Hengster P, Pohl P, Rainer J, Reibnegger G, Tibyampansha D, Werner ER, Dierich MP, Gerstenbrand F, Wachter H. Mitt.Oesterr.Ges.Tropenmed.Parasitol. (1988) 10: 269-279.
La neopterine comme marqueur potentiel de l evolution des infections a HIV chez les toxicomanes. Unterweger B, Fuchs D, Fleischhacker WW, Hausen A, Hengster P, Reibnegger G, Werner ER, Hinterhuber H, Dierich MP, Wachter H. Cancer Commun. (1988) 2: 27-34.
Neopterin bei Infektionen mit dem humanen Immunmangelvirus (HIV). Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP. Deutsch.Med.Wochenschr. (1988) 113: 1890-1897.
Tryptophan degradation in patients infected by human immunodeficiency virus. Werner ER, Fuchs D, Hausen A, Jäger H, Reibnegger G, Werner-Felmayer G, Dierich MP, Wachter H. Biol.Chem.Hoppe Seyler (1988) 369: 337-340.
Influence of interferon-gamma and extracellular tryptophan on indoleamine 2,3-dioxygenase activity in T24 cells as determined by a non-radiometric assay. Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G, Wachter H. Biochem.J. (1988) 256: 537-541.
Effect of interferon-gamma on tryptophan and pteridine metabolism of human cells. Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G, Wachter H. J.Nat.Cancer Inst. (1988) 80: 974.
HIV seroconversion in health care workers. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. J.Am.Med.Assoc. (1987) 258: 2525-2526.
Activated T-cells in addition to LAV/HTLV-III infection: A necessary precondition for development of AIDS. Fuchs D, Hausen A, Hoefler E, Schönitzer D, Werner ER, Dierich MP, Hengster P, Reibnegger G, Schulz T, Wachter H. Cancer Detect.Prevent. (1987) Suppl.1: 583-587.
HIV vaccination and blood transfusion. Fuchs D, Hausen A, Reibnegger G, Schönitzer D, Werner ER, Dierich MP, Wachter H. Nature (1987) 330: 702-703.
Psoriasis, gamma-interferon, and the acquired immunodeficiency syndrome. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. Ann.Intern.Med. (1987) 106: 165.
Aktiviertes zelluläres Immunsystem und HIV Infektion; Bedeutung des Neopterin. Fuchs D, Hausen A, Hengster P, Reibnegger G, Rössler H, Schönitzer D, Schulz T, Unterweger B, Werner ER, Reissigl H, Hinterhuber H, Dierich MP, Wachter H. Ber.OeGKC (1987) 10: 79-86.
In vivo activation of CD4+ cells in AIDS. Fuchs D, Hausen A, Hengster P, Reibnegger G, Schulz T, Werner ER, Dierich MP, Wachter H. Science (1987) 235: 356.
Immune status of drug abusers. Fuchs D, Hausen A, Reibnegger G, Schönitzer D, Unterweger B, Blecha HG, Hengster P, Rössler H, Schulz T, Werner ER, Dierich MP, Hinterhuber H, Schauenstein K, Traill K, Wachter H. Cancer Detect.Prevent. (1987) Suppl.1: 535-541.
Immunosuppressants in treatment of patients with AIDS. Hausen A, Fuchs D, Reibnegger G, Werner ER, Dierich MP, Wachter H. Lancet (1987) ii: 214-215.
Neopterin excretion does not correlate with erythrocyte sedimentation rate. Hausen A, Fuchs D, Reibnegger G, Werner ER, Wachter H. Klin.Wochenschr. (1987) 65: 1173.
Neopterin as discriminating and prognostic parameter in healthy homosexuals, ARC and AIDS patients. Hutterer J, Fuchs D, Eder G, Hausen A, Knapp W, Köller U, Reibnegger G, Werner ER, Wachter H, Stingl G, Wolff K. Wien.Klin.Wochenschr. (1987) 99: 531-535.
Allogeneic activation is increased during pregnancy. A risk factor in HIV infection? Mayr P, Fuchs D, Fuith LC, Hausen A, Reibnegger G, Werner ER, Wachter H. Brit.J.Obstet.Gynecol. (1987) 94: 1000-1001.
Potential of urinary neopterin excretion in differentiating chronic non-A,non-B hepatitis from fatty liver. Prior C, Fuchs D, Hausen A, Judmaier G, Reibnegger G, Werner ER, Vogel W, Wachter H. Lancet (1987) ii: 1235-1237.
Immunity in sarcoidosis. Prior C, Frank A, Fuchs D, Hausen A, Judmaier G, Reibnegger G, Werner ER, Wachter H. Lancet (1987) ii: 741.
Neopterinausscheidung bei Patienten mit Sarkoidose: Beziehung zum radiologischen Stadium. Prior C, Frank A, Fuchs D, Hausen A, Judmaier G, Reibnegger G, Werner ER, Wachter H. Prax.Pneumol. (1987) 41: 920-921.
The dependence of cell-mediated immune activation in malaria on age and endemicity. Reibnegger G, Fuchs D, Hausen A, Schmutzhard E, Werner ER, Wachter H. Trans.Roy.Soc.Trop.Med.Hyg. (1987) 81: 729-733.
Theoretical implications of cellular immune reactions against helper lymphocytes infected by an immune system retrovirus. Reibnegger G, Fuchs D, Hausen A, Werner ER, Dierich MP, Wachter H. Proc.Natl.Acad.Sci.(USA) (1987) 84: 7270-7275.
Activated macrophages and cancer. Reibnegger G, Fuchs D, Hausen A, Werner ER, Wachter H. Lancet (1987) i: 1439.
Clinical significance of neopterin for prognosis and follow-up in ovarian cancer. Reibnegger G, Hetzel H, Fuchs D, Fuith LC, Hausen A, Werner ER, Wachter H. Cancer Res. (1987) 47: 4977-4981.
Role of activated T lymphocytes in Mycosis Fungoides. Wehrmann W, Bauer R, Fuchs D, Hausen A, Reibnegger G, Werner ER, Wachter H. Eur.J.Clin.Microbiol. (1987) 6: 210-211.
Determination of neopterin in serum and urine. Werner ER, Bichler A, Daxenbichler G, Fuchs D, Fuith LC, Hausen A, Hetzel H, Reibnegger G, Wachter H. Clin.Chem. (1987) 33: 62-66.
Human macrophages degrade tryptophan upon induction by interferon-gamma. Werner ER, Bitterlich G, Fuchs D, Hausen A, Reibnegger G, Szabo G, Dierich MP, Wachter H. Life Sci. (1987) 41: 273-280.
Simultaneous determination of neopterin and creatinine in serum with solid phase extraction and on-line elution liquid chromatography. Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. Clin.Chem. (1987) 33: 2028-2033.
Interferon-gamma-induced degradation of tryptophan by human cells in vitro. Werner ER, Hirsch-Kauffmann M, Fuchs D, Hausen A, Reibnegger G, Schweiger M, Wachter H. Biol.Chem.Hoppe Seyler (1987) 368: 1407-1412.
Neopterin – Bedeutung für die Diagnose. Fuchs D, Hausen A, Reibnegger G, Werner ER, Wachter H. Deutsch.Apotheker Ztg. (1986) 126: 723-728.
Immunosuppressants in patients with AIDS. Hausen A, Dierich MP, Fuchs D, Hengster P, Reibnegger G, Schulz T, Werner ER, Wachter H. Nature (1986) 320: 114.
HTLV-III-Durchseuchung bei Personen mit intravenösem Drogenmibbrauch. Hengster P, Blecha HG, Deinhardt F, Erfle V, Fuchs D, Goebel FD, Gürtler LG, Hausen A, Hinterhuber H, Reibnegger G, Rössler H, Schauenstein K, Schönitzer D, Schulz T, Traill K, Werner ER, Wachter H, Dierich MP. Deutsch.Med.Wochenschr. (1986) 111: 453-457.
Urinary neopterin, a marker of clinical activity in patients with Crohn`s disease. Prior C, Bollbach R, Fuchs D, Hausen A, Judmaier G, Niederwieser D, Reibnegger G, Rotthauwe HW, Werner ER, Wachter H. Clin.Chim.Acta (1986) 155: 11-22.
A simple index relating clinical activity in Crohn`s disease with T cell activation: Hematokrit, frequency of liquid stools and urinary neopterin as parameters. Reibnegger G, Bollbach R, Fuchs D, Hausen A, Judmaier G, Prior C, Rotthauwe HW, Werner ER, Wachter H. Immunobiol. (1986) 173: 1-11.
Urinary neopterin reflects clinical activity in patients with rheumatoid arthritis. Reibnegger G, Egg D, Fuchs D, Günther R, Hausen A, Werner ER, Wachter H. Arthritis Rheum. (1986) 29: 1063-1070.
Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix. Reibnegger GJ, Bichler AH, Dapunt O, Fuchs DN, Fuith LC, Hausen A, Hetzel H, Lutz H, Werner ER, Wachter H. Cancer Res. (1986) 46: 950-955.
Are conditions linked with T-cell stimulation necessary for progressive HTLV-III infection? Wachter H, Fuchs D, Hausen A, Hengster P, Reibnegger G, Reissigl H, Schönitzer D, Schulz T, Werner ER, Dierich MP. Lancet (1986) i: 97.
Who will get AIDS? Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP. Lancet (1986) ii: 1216-1217.
Die Aktivierung des Makrophagen/Lymphozyten-Systems bei AIDS, ARC- und AIDS-Risikogruppen. Wachter H, Blecha HG, Fuchs D, Hausen A, Hengster P, Hinterhuber H, Reibnegger G, Reissigl H, Rössler H, Schönitzer D, Schulz T, Werner ER, Dierich MP. Wien.Klin.Wochenschr. (1986) 98: 449-454.
Drogenabhängige in Österreich – eine Risikogruppe für AIDS. Blecha HG, Deinhardt F, Dierich MP, Erfle V, Fuchs D, Goebel FD, Gürtler LG, Hausen A, Hengster P, Reibnegger G, Reissigl H, Rössler H, Schauenstein K, Schönitzer D, Schulz T, Traill K, Werner ER, Wachter H, Hinterhuber H. Neuropsychiatrie (1985) 1: 24-28.
Are homosexuals less at risk of AIDS than intravenous drug abusers and haemophiliacs? Fuchs D, Dierich MP, Hausen A, Hengster P, Reibnegger G, Schulz T, Werner ER, Wachter H. Lancet (1985) ii: 1130.
Die Bedeutung der Neopterinbestimmung bei Patienten mit AIDS und bei Risikogruppen. Fuchs D, Hausen A, Hinterhuber H, Kathke N, Krahnke H, Lutz H, Reibnegger G, Rössler H, Schönitzer D, Spira TJ, Vinazzer H, Werner ER, Wachter H. Mitt.Oesterr.Ges.Tropenmed.Parasitol. (1985) 7: 11-17.
Statistical evaluation of urinary neopterin in the prognosis and follow-up of patients with cervical cancer. Reibnegger G, Bichler A, Dapunt O, Fuchs D, Fuith LC, Hausen A, Hetzel H, Lutz H, Werner ER, Wachter H. Tumor Diagnostik & Therapie (1985) 6: 215-222.
Identification of 3-hydroxyanthranilic acid in mixed lymphocyte cultures. Werner ER, Lutz H, Fuchs D, Hausen A, Huber C, Niederwieser D, Pfleiderer W, Reibnegger G, Troppmair J, Wachter H. Biol.Chem.Hoppe Seyler (1985) 366: 99-102.
Structure dependence of ESR spectra of Cu(II) complexes of aliphatic and tryptophan containing dipeptides and ATP. Werner ER, Rode BM. Inorg.Chim.Acta (1984) 93: 27-32.
Complex formation of Cu(II) with ATP and aliphatic dipeptides in aqueous solution. Werner ER, Rode BM. Inorg.Chim.Acta (1984) 91: 217-222.
ESR and titrimetric investigation of ATP-copper solutions. Werner ER, Rode BM. Inorg.Chim.Acta (1983) 80: 39-46.
Complex formation in the blood of Helix Pomatia. Werner ER, Rode BM. Comp.Biochem.Physiol. (1983) 74: 165-168
Preactivated T-cells in cancer patients with poor prognosis. Fuchs D, Fuith LC, Hausen A, Hetzel H, Reibnegger GJ, Werner ER, Wachter H. Cancer Detect.Prevent. (1988) 12: 97-103.
Cytomegalovirus infection. Fuchs D, Hausen A, Reibnegger G, Werner ER, Wachter H. Wien.Klin.Wochenschr. (1988) 100: 303.
Toxic properties of the mushroom Cortinarius orellanus. I.Chemical characterization of the main toxin of Cortinarius orellanus (Fries) and Cortinarius speciosissimus (Kühn & Romagn) and acute toxicity in mice. Prast H, Werner ER, Pfaller W, Moser M. Arch.Toxicol. (1988) 62: 81-88.
Urinary neopterin excretion in pulmonary sarcoidosis: correlation to clinical course of the disease. Prior C, Frank A, Fuchs D, Hausen A, Judmaier G, Reibnegger G, Werner ER, Wachter H. Clin.Chim.Acta (1988) 177: 211-220.
Approach to define „normal aging“ in man. Immune function, serum lipids, lipoproteins and neopterin levels. Reibnegger G, Huber LA, Jürgens G, Schönitzer D, Werner ER, Wachter H, Wick G, Traill KN. Mech.Ageing Dev. (1988) 46: 67-82.
Urinary neopterin levels in acute viral hepatitis. Reibnegger G, Auhuber I, Fuchs D, Hausen A, Judmaier G, Prior C, Werner ER, Wachter H. Hepatology (1988) 8: 771-774.
Pterins as biochemical tests for diagnosis and management of patients with malignant lymphoma and leukemia. Reibnegger G, Fuchs D, Hausen A, Werner ER, Wachter H. Clin.Chim.Acta (1988) 173: 233-234.
Neopterin in der HIV-Infektion. Reibnegger G, Fuchs D, Hausen A, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H. Antibiot.Monitor. (1988) 81-82.
The prognostic value of neopterin as a marker for the immune status in malignancy. Reibnegger G, Fuchs D, Fuith LC, Hausen A, Hetzel H, Werner ER, Wachter H. J.Tumor Marker Oncol. (1988) 3: 121-125.
Retrovirale Infektionen in Norwest-Tanzania (HIV 1, HIV II, HTLV I). Schmutzhard E, Fuchs D, Hausen A, Hengster P, Pohl P, Rainer J, Reibnegger G, Tibyampansha D, Werner ER, Dierich MP, Gerstenbrand F, Wachter H. Mitt.Oesterr.Ges.Tropenmed.Parasitol. (1988) 10: 269-279.
La neopterine comme marqueur potentiel de l evolution des infections a HIV chez les toxicomanes. Unterweger B, Fuchs D, Fleischhacker WW, Hausen A, Hengster P, Reibnegger G, Werner ER, Hinterhuber H, Dierich MP, Wachter H. Cancer Commun. (1988) 2: 27-34.
Neopterin bei Infektionen mit dem humanen Immunmangelvirus (HIV). Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP. Deutsch.Med.Wochenschr. (1988) 113: 1890-1897.
Tryptophan degradation in patients infected by human immunodeficiency virus. Werner ER, Fuchs D, Hausen A, Jäger H, Reibnegger G, Werner-Felmayer G, Dierich MP, Wachter H. Biol.Chem.Hoppe Seyler (1988) 369: 337-340.
Influence of interferon-gamma and extracellular tryptophan on indoleamine 2,3-dioxygenase activity in T24 cells as determined by a non-radiometric assay. Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G, Wachter H. Biochem.J. (1988) 256: 537-541.
Effect of interferon-gamma on tryptophan and pteridine metabolism of human cells. Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G, Wachter H. J.Nat.Cancer Inst. (1988) 80: 974.
HIV seroconversion in health care workers. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. J.Am.Med.Assoc. (1987) 258: 2525-2526.
Activated T-cells in addition to LAV/HTLV-III infection: A necessary precondition for development of AIDS. Fuchs D, Hausen A, Hoefler E, Schönitzer D, Werner ER, Dierich MP, Hengster P, Reibnegger G, Schulz T, Wachter H. Cancer Detect.Prevent. (1987) Suppl.1: 583-587.
HIV vaccination and blood transfusion. Fuchs D, Hausen A, Reibnegger G, Schönitzer D, Werner ER, Dierich MP, Wachter H. Nature (1987) 330: 702-703.
Psoriasis, gamma-interferon, and the acquired immunodeficiency syndrome. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. Ann.Intern.Med. (1987) 106: 165.
Aktiviertes zelluläres Immunsystem und HIV Infektion; Bedeutung des Neopterin. Fuchs D, Hausen A, Hengster P, Reibnegger G, Rössler H, Schönitzer D, Schulz T, Unterweger B, Werner ER, Reissigl H, Hinterhuber H, Dierich MP, Wachter H. Ber.OeGKC (1987) 10: 79-86.
In vivo activation of CD4+ cells in AIDS. Fuchs D, Hausen A, Hengster P, Reibnegger G, Schulz T, Werner ER, Dierich MP, Wachter H. Science (1987) 235: 356.
Immune status of drug abusers. Fuchs D, Hausen A, Reibnegger G, Schönitzer D, Unterweger B, Blecha HG, Hengster P, Rössler H, Schulz T, Werner ER, Dierich MP, Hinterhuber H, Schauenstein K, Traill K, Wachter H. Cancer Detect.Prevent. (1987) Suppl.1: 535-541.
Immunosuppressants in treatment of patients with AIDS. Hausen A, Fuchs D, Reibnegger G, Werner ER, Dierich MP, Wachter H. Lancet (1987) ii: 214-215.
Neopterin excretion does not correlate with erythrocyte sedimentation rate. Hausen A, Fuchs D, Reibnegger G, Werner ER, Wachter H. Klin.Wochenschr. (1987) 65: 1173.
Neopterin as discriminating and prognostic parameter in healthy homosexuals, ARC and AIDS patients. Hutterer J, Fuchs D, Eder G, Hausen A, Knapp W, Köller U, Reibnegger G, Werner ER, Wachter H, Stingl G, Wolff K. Wien.Klin.Wochenschr. (1987) 99: 531-535.
Allogeneic activation is increased during pregnancy. A risk factor in HIV infection? Mayr P, Fuchs D, Fuith LC, Hausen A, Reibnegger G, Werner ER, Wachter H. Brit.J.Obstet.Gynecol. (1987) 94: 1000-1001.
Potential of urinary neopterin excretion in differentiating chronic non-A,non-B hepatitis from fatty liver. Prior C, Fuchs D, Hausen A, Judmaier G, Reibnegger G, Werner ER, Vogel W, Wachter H. Lancet (1987) ii: 1235-1237.
Immunity in sarcoidosis. Prior C, Frank A, Fuchs D, Hausen A, Judmaier G, Reibnegger G, Werner ER, Wachter H. Lancet (1987) ii: 741.
Neopterinausscheidung bei Patienten mit Sarkoidose: Beziehung zum radiologischen Stadium. Prior C, Frank A, Fuchs D, Hausen A, Judmaier G, Reibnegger G, Werner ER, Wachter H. Prax.Pneumol. (1987) 41: 920-921.
The dependence of cell-mediated immune activation in malaria on age and endemicity. Reibnegger G, Fuchs D, Hausen A, Schmutzhard E, Werner ER, Wachter H. Trans.Roy.Soc.Trop.Med.Hyg. (1987) 81: 729-733.
Theoretical implications of cellular immune reactions against helper lymphocytes infected by an immune system retrovirus. Reibnegger G, Fuchs D, Hausen A, Werner ER, Dierich MP, Wachter H. Proc.Natl.Acad.Sci.(USA) (1987) 84: 7270-7275.
Activated macrophages and cancer. Reibnegger G, Fuchs D, Hausen A, Werner ER, Wachter H. Lancet (1987) i: 1439.
Clinical significance of neopterin for prognosis and follow-up in ovarian cancer. Reibnegger G, Hetzel H, Fuchs D, Fuith LC, Hausen A, Werner ER, Wachter H. Cancer Res. (1987) 47: 4977-4981.
Role of activated T lymphocytes in Mycosis Fungoides. Wehrmann W, Bauer R, Fuchs D, Hausen A, Reibnegger G, Werner ER, Wachter H. Eur.J.Clin.Microbiol. (1987) 6: 210-211.
Determination of neopterin in serum and urine. Werner ER, Bichler A, Daxenbichler G, Fuchs D, Fuith LC, Hausen A, Hetzel H, Reibnegger G, Wachter H. Clin.Chem. (1987) 33: 62-66.
Human macrophages degrade tryptophan upon induction by interferon-gamma. Werner ER, Bitterlich G, Fuchs D, Hausen A, Reibnegger G, Szabo G, Dierich MP, Wachter H. Life Sci. (1987) 41: 273-280.
Simultaneous determination of neopterin and creatinine in serum with solid phase extraction and on-line elution liquid chromatography. Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. Clin.Chem. (1987) 33: 2028-2033.
Interferon-gamma-induced degradation of tryptophan by human cells in vitro. Werner ER, Hirsch-Kauffmann M, Fuchs D, Hausen A, Reibnegger G, Schweiger M, Wachter H. Biol.Chem.Hoppe Seyler (1987) 368: 1407-1412.
Neopterin – Bedeutung für die Diagnose. Fuchs D, Hausen A, Reibnegger G, Werner ER, Wachter H. Deutsch.Apotheker Ztg. (1986) 126: 723-728.
Immunosuppressants in patients with AIDS. Hausen A, Dierich MP, Fuchs D, Hengster P, Reibnegger G, Schulz T, Werner ER, Wachter H. Nature (1986) 320: 114.
HTLV-III-Durchseuchung bei Personen mit intravenösem Drogenmibbrauch. Hengster P, Blecha HG, Deinhardt F, Erfle V, Fuchs D, Goebel FD, Gürtler LG, Hausen A, Hinterhuber H, Reibnegger G, Rössler H, Schauenstein K, Schönitzer D, Schulz T, Traill K, Werner ER, Wachter H, Dierich MP. Deutsch.Med.Wochenschr. (1986) 111: 453-457.
Urinary neopterin, a marker of clinical activity in patients with Crohn`s disease. Prior C, Bollbach R, Fuchs D, Hausen A, Judmaier G, Niederwieser D, Reibnegger G, Rotthauwe HW, Werner ER, Wachter H. Clin.Chim.Acta (1986) 155: 11-22.
A simple index relating clinical activity in Crohn`s disease with T cell activation: Hematokrit, frequency of liquid stools and urinary neopterin as parameters. Reibnegger G, Bollbach R, Fuchs D, Hausen A, Judmaier G, Prior C, Rotthauwe HW, Werner ER, Wachter H. Immunobiol. (1986) 173: 1-11.
Urinary neopterin reflects clinical activity in patients with rheumatoid arthritis. Reibnegger G, Egg D, Fuchs D, Günther R, Hausen A, Werner ER, Wachter H. Arthritis Rheum. (1986) 29: 1063-1070.
Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix. Reibnegger GJ, Bichler AH, Dapunt O, Fuchs DN, Fuith LC, Hausen A, Hetzel H, Lutz H, Werner ER, Wachter H. Cancer Res. (1986) 46: 950-955.
Are conditions linked with T-cell stimulation necessary for progressive HTLV-III infection? Wachter H, Fuchs D, Hausen A, Hengster P, Reibnegger G, Reissigl H, Schönitzer D, Schulz T, Werner ER, Dierich MP. Lancet (1986) i: 97.
Who will get AIDS? Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP. Lancet (1986) ii: 1216-1217.
Die Aktivierung des Makrophagen/Lymphozyten-Systems bei AIDS, ARC- und AIDS-Risikogruppen. Wachter H, Blecha HG, Fuchs D, Hausen A, Hengster P, Hinterhuber H, Reibnegger G, Reissigl H, Rössler H, Schönitzer D, Schulz T, Werner ER, Dierich MP. Wien.Klin.Wochenschr. (1986) 98: 449-454.
Drogenabhängige in Österreich – eine Risikogruppe für AIDS. Blecha HG, Deinhardt F, Dierich MP, Erfle V, Fuchs D, Goebel FD, Gürtler LG, Hausen A, Hengster P, Reibnegger G, Reissigl H, Rössler H, Schauenstein K, Schönitzer D, Schulz T, Traill K, Werner ER, Wachter H, Hinterhuber H. Neuropsychiatrie (1985) 1: 24-28.
Are homosexuals less at risk of AIDS than intravenous drug abusers and haemophiliacs? Fuchs D, Dierich MP, Hausen A, Hengster P, Reibnegger G, Schulz T, Werner ER, Wachter H. Lancet (1985) ii: 1130.
Die Bedeutung der Neopterinbestimmung bei Patienten mit AIDS und bei Risikogruppen. Fuchs D, Hausen A, Hinterhuber H, Kathke N, Krahnke H, Lutz H, Reibnegger G, Rössler H, Schönitzer D, Spira TJ, Vinazzer H, Werner ER, Wachter H. Mitt.Oesterr.Ges.Tropenmed.Parasitol. (1985) 7: 11-17.
Statistical evaluation of urinary neopterin in the prognosis and follow-up of patients with cervical cancer. Reibnegger G, Bichler A, Dapunt O, Fuchs D, Fuith LC, Hausen A, Hetzel H, Lutz H, Werner ER, Wachter H. Tumor Diagnostik & Therapie (1985) 6: 215-222.
Identification of 3-hydroxyanthranilic acid in mixed lymphocyte cultures. Werner ER, Lutz H, Fuchs D, Hausen A, Huber C, Niederwieser D, Pfleiderer W, Reibnegger G, Troppmair J, Wachter H. Biol.Chem.Hoppe Seyler (1985) 366: 99-102.
Structure dependence of ESR spectra of Cu(II) complexes of aliphatic and tryptophan containing dipeptides and ATP. Werner ER, Rode BM. Inorg.Chim.Acta (1984) 93: 27-32.
Complex formation of Cu(II) with ATP and aliphatic dipeptides in aqueous solution. Werner ER, Rode BM. Inorg.Chim.Acta (1984) 91: 217-222.
ESR and titrimetric investigation of ATP-copper solutions. Werner ER, Rode BM. Inorg.Chim.Acta (1983) 80: 39-46.
Complex formation in the blood of Helix Pomatia. Werner ER, Rode BM. Comp.Biochem.Physiol. (1983) 74: 165-168